Schwab Dividend ETF Adjusts Holdings Amid Market Volatility

The Schwab U.S. Dividend Equity ETF (SCHD) has completed its annual reconstitution, removing 22 stocks and adding 25 new ones. This adjustment has led to a significant shift in sector exposure, with energy and materials holdings decreasing by 7.1% and 3%, respectively. The changes come amid a challenging start to 2026 for major market indexes and blue-chip stocks. Dividend stocks remain a popular choice for investors seeking passive income, as they offer payouts that act as a buffer against market volatility. The ETF's strategy focuses on companies that meet four key criteria: five-year dividend growth, return on equity, cash flow to debt, and dividend yield. This vetting process aims to identify sustainable dividend payers while minimizing the risk of yield traps. The reconstitution saw notable exits including AbbVie, Cisco Systems, and Valero, while UnitedHealth Group, Procter & Gamble, and Abbott Laboratories were added to the portfolio. Healthcare and technology sectors gained 3.6% and 3.4% exposure, respectively, following the changes. The decision to reduce energy exposure is particularly noteworthy given the sector's strong performance in early 2026, driven by geopolitical tensions in the Middle East that have boosted oil prices. While the ETF's dividend yield remains more than three times the S&P 500 average, it does not pursue ultra-high yields that may come with greater risk. The fund continues to be positioned as a reliable option for investors seeking consistent, growing passive income through a diversified portfolio of dividend-paying stocks.